No Data
No Data
Needham Initiates Neumora Therapeutics(NMRA.US) With Buy Rating, Announces Target Price $23
Needham analyst Ami Fadia initiates coverage on $Neumora Therapeutics(NMRA.US)$ with a buy rating, and sets the target price at $23.According to TipRanks data, the analyst has a success rate of 47.4%
Needham Initiates Coverage On Neumora Therapeutics With Buy Rating, Announces Price Target of $23
Needham analyst Ami Fadia initiates coverage on Neumora Therapeutics (NASDAQ:NMRA) with a Buy rating and announces Price Target of $23.
Express News | Neumora Therapeutics Inc : Needham Initiates Coverage With Buy Rating; Target Price $23
Express News | Neumora Therapeutics Shares Are Trading Higher After Mizuho Initiated Coverage on the Stock With an Outperform Rating and Announced a $20 Price Target
Mizuho Securities Initiates Neumora Therapeutics(NMRA.US) With Buy Rating, Announces Target Price $20
Mizuho Securities analyst Graig Suvannavejh initiates coverage on $Neumora Therapeutics(NMRA.US)$ with a buy rating, and sets the target price at $20.According to TipRanks data, the analyst has a
Neumora Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/08/2024 95.12% Mizuho → $20 Initiates Coverage On → Outperform 03/28/2024 202.44% RBC Capital → $31 Rei
No Data